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Malaria, the most common vector-borne parasite infection worldwide, results from infec-
tion by Plasmodium species. Approximately 80% of malaria cases are caused by P. vivax, 
which is broadly distributed from tropical to temperate regions; P. falciparum is the second 
most common infectious species. P. malariae and P. ovale are responsible for a relatively 
small proportion of malaria cases. Here, we report the case of a 23-yr-old Korean woman 
who acquired a P. malariae infection while visiting the Republic of Ghana in West Africa 
for business. She was diagnosed with P. malariae malaria on the basis of peripheral blood 
smear (PBS) and species-specific conventional and real-time PCR assays for 18S rRNA. 
She was treated with hydroxychloroquine, and the resulting PBS examination on day 2 
suggested that negative conversion occurred. At her 1-month follow-up, however, both the 
PBS examination and molecular test for malaria demonstrated recurrent parasitemia. We 
started rescue therapy with mefloquine, and the patient recovered successfully. This is an 
important finding suggesting possible late recrudescence of a chloroquine-resistant P. ma-
lariae strain identified not only by its morphological features, but also by molecular tests.
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INTRODUCTION
Malaria is a human infection that has been documented since 
ancient times. It is a vector-borne disease caused by Plasmo-
dium species and transmitted by Anopheles mosquitoes [1]. An-
nually, more than 300-500 million cases of malaria are reported 
worldwide, and 1.5-2.7 million of these patients die from malaria 
infections every year [2]. In Korea, malaria cases are regularly 
reported. Since the re-emergence of P. vivax in the early 1990s, 
most malaria cases occurring in Korea have resulted from P. 
vivax infections. According to the Korea Centers for Disease 
Control and Prevention (KCDC), induced malaria comprises 
1-4% of all malaria cases in Korea, in the following order of fre-
quency: P. falciparum (41.5%), P. vivax (36.8%), and malaria 
caused by other species [3].
  Many cases of P. malariae infections were diagnosed in Korea 
from the 1930s to the 1950s, and a case of co-infection with Ba-
besia and P. malariae malaria was reported in 1998. However, 
these were diagnosed based only on morphologic features [4, 
5]. Here, we report a case of imported malaria that was caused 
by P. malariae. In combination with peripheral blood smear 
(PBS), conventional and real-time PCR for 18S RNA were also 
conducted for a conclusive diagnosis. 
CASE REPORT
1. Clinical history and laboratory findings
A previously healthy 23-yr-old woman visited the emergency 
room (ER) because she experienced chills for 3 days, which 
were exacerbated at night and were accompanied by headaches 
and rhinorrhea. Three weeks prior to her ER visit, she had trav-
elled on business to the Republic of Ghana for 1 week. At the 
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time of her visit to the ER, her body temperature was 36.9°C, 
and her other physical examination results were nonspecific. 
The laboratory tests results were as follows: hemoglobin level, 
13.9 g/dL; white blood cell count, 4.4×10
9/L (neutrophils, 72.0%; 
lymphocytes, 13.8%; monocytes, 9.6%; eosinophils, 4.4%; and 
basophils, 0.2%); platelet count, 135×10
9/L; and C-reactive pro-
tein (CRP) level, 1.20 mg/dL (slightly above normal). Wright-Gi-
emsa staining of the PBS was performed to screen for malarial 
parasites. However, the smear did not show the presence of 
malarial parasites. Therefore, the patient was discharged, and 
upper respiratory tract infection was suspected. 
  Six days later, she visited the outpatient clinic for follow-up 
and presented with diarrhea and abdominal discomfort in addi-
tion to chills. Her self-recorded body temperature was 40.3°C. 
Laboratory investigations performed at that time showed that her 
hemoglobin level was 12.6 g/dL and white blood cell count was 
6.3×10
9/L (metamyelocytes, 1%; segmented neutrophils, 40%; 
lymphocytes, 42%; monocytes, 9%; eosinophils, 5%; and baso-
phils, 3%); furthermore, her platelet count had decreased to 95
×10
9/L, and her CRP levels had increased to 5.45 mg/dL. The 
liver function test, which was normal at first visit to the ER, 
showed a slight increase in AST and ALT levels to 77 IU/L and 
84 IU/L, respectively. She was admitted to our medical center for 
further evaluation, and 3 pairs of blood culture and malaria tests 
(PBS and 2 different molecular tests) were performed. The blood 
cultures yielded negative results. The results of Wright-Giemsa 
staining on the PBS and the molecular tests for malaria are shown 
in Fig. 1 A-C (at the time of presentation), Fig. 2, and Fig. 3. She 
was treated with oral hydroxychloroquine (Oxiklorin; immediate 
dose of 800 mg, followed by 400-mg doses at 12, 24, and 36 hr) 
and was later discharged. Although malarial parasites were not 
observed on the PBS 2 days later and the patient was symptom-
free until the next follow-up, the PBS and real-time PCR results 
at the 1-month follow-up showed recurrent parasitemia (Fig. 1 
D-E, and Fig. 3). She was successfully treated with oral meflo-
quine (Lariam; immediate dose of 750 mg, followed by 500 mg 
at 24 hr), and the results of the PBS and the molecular tests 
performed 7 days after completing this therapy were negative.
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Fig. 2. Conventional PCR results for Plasmodium species-specific 
18S rRNA. A 144-bp fragment corresponding to P. malariae was 
detected from the PCR-amplified product of the patient’s blood 
sample. M: DNA size marker. 
Abbreviations: DW, distilled water; NC, negative control; PC, positive control; 
Pt, the patient.
E
Fig. 1. Peripheral blood at the time of presentation (A, B, C) and at the 1-month follow-up showing a 
few parasites (D, E) by Wright-Giemsa staining (×1,000). (A) Amoeboid form of a mature trophozoite; 
(B) an early schizont in a contracted cell; (C) a late schizont with 8 merozoites and central coarse dark 
pigment; (D) angular form of a mature trophozoite; (E) a late schizont with symmetrically arranged 
merozoites.
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2. Molecular diagnosis
For the 18S rRNA, conventional PCR was performed. DNA was 
extracted from the blood sample of the patient using the QIAamp 
DNA Blood Mini Kit (Qiagen, Hilden, Germany). Four pairs of 
species-specific primers (rFAL1/rFAL3 for P. falciparum, rVIV1/
rVIV2 for P. vivax, rMAL1/rMAL2 for P. malariae, and rOVA3/
rOVA4 for P. ovale) that had been reported in a previous study 
were used [6, 7]. Amplification was performed in a 50-μL reac-
tion mixture that contained 5 μL of extracted DNA, 2 μL of 10 
pmol/μL primer (each), 4 μL of 2.5 mM dNTP, 0.25 μL of Taq 
polymerase (Takara, Shiga, Japan), and 5 μL of 10× buffer. All 
the PCR cycling protocols incorporated an initial denaturation 
step at 95°C for 3 min; 35 amplification cycles of 95°C for 40 
sec, 53°C for 1 min, and 72°C for 1 min; and a final extension 
step at 72°C for 5 min. PCR products were visualized using 2% 
agarose gel electrophoresis and subsequent ethidium bromide 
staining. Only P. malariae was detected in the patient’s periph-
eral blood sample (Fig. 2).
  The 18S rRNA real-time PCR assays for the 4 Plasmodium 
species, which produce 205-bp, 117-bp, 144-bp, and 456-bp 
amplicons, respectively, were also performed using previously 
reported primers (the 4 forward species-specific primers were 
FWfal, FWviv, FWmal, and FWova, respectively) [8]. The com-
ponents of the real-time PCR reaction mixture were as follows: 
2.0 ng of DNA template with 2.0 μL of LC FastStart DNA Master 
SYBR Green I (Roche, Penzberg, Germany), 0.4 μL of each 
primer (10 pmol/μL), and 1.6 μL of 25 mM MgCl2 in a final vol-
ume of 20.0 μL. The PCR program used was as follows: 94°C for 
15 min and 40 cycles of 94°C for 5 sec, 58°C for 5 sec, and 72°
C for 10 sec. The program for analytic melting was as follows: 
95°C for 5 sec and 60°C for 30 sec, followed by an increase in 
temperature to 99°C with a 0.2°C/sec ramp rate. The real-time 
PCR assay correctly identified the presence of P. malariae (Fig. 3).
Fig. 3. Amplification plots and melting curve analyses of the 4 Plasmodium species-specific 18S rRNA real-time PCR assays showing the 
presence of P. malariae. Positive results were obtained only for P. malariae (A). Three consecutive analyses of Plasmodium malariae-specif-
ic real-time PCR were performed, showing persistent positivity at the 1-month follow-up (2011.09.28) and then final negative conversion 
(2011.10.04) (B). The melting temperature (Tm) for P. malariae was approximately 76.36-76.86°C. 
Abbreviations: Pt, the patient; DW, distilled water; PC, positive control.
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DISCUSSION
Malaria is the most common parasitic disease worldwide [1]. P. 
vivax, P. falciparum, P. ovale, P. malariae, and the recently emerg-
ing P. knowlesi are the Plasmodium species known to cause hu-
man infections [9]. Among these species, P. vivax is responsible 
for 80% of all human malaria cases because of its prevalence in 
a wide range of areas, from tropical to temperate zones. The sec-
ond most common malaria-causing species is P. falciparum. P. 
falciparum is limited to only tropical areas; however, it causes se-
vere symptoms and a high mortality rate. Therefore, many coun-
tries are involved in a malaria control project sponsored by the 
WHO to achieve advances in malaria control [10]. The 2 species 
mentioned above are responsible for more than 95% of human 
malaria cases, and the WHO eradication projects focus on these 
species. In contrast, the importance of P. malariae and P. ovale 
infections is usually overlooked.
  The Republic of Ghana is located in West Africa, where the 
prevalence of malaria is higher than in East Africa [11]. Indeed, 
in Ghana, the entire nation is at the risk of malaria infection. A 
very large number of cases (3.7 million cases of suspected ma-
laria and 1.9 million cases of probable or confirmed malaria) 
were reported in 2009 [12]. The country has been involved in 
the malaria control program conducted by the WHO since early 
2000. 
  Malaria infection is suspected in patients experiencing the 
characteristic cyclic fever, having a history of habitation or visit 
to an endemic area, and presenting with other conditions, such 
as transfusion history. Details of the medical examination can 
help identify malaria to the species level. The average incuba-
tion time, for example, is influenced by the species of Plasmo-
dium and may provide information about the source of infec-
tion. The incubation time for P. falciparum infections is 9-14 
days, while P. vivax has an incubation time of 12-17 days and P. 
malariae has an incubation time of 18-40 days, which is consid-
ered relatively long [13]. In this case, although the exact time of 
exposure was unknown, the supposed incubation time based 
on travel history was 14-21 days. This information assisted par-
tially in excluding P. falciparum infection.
  Among the various diagnostic approaches, the common choice 
of method for diagnosis is microscopic examination of blood 
films and confirmation of parasites. Although a physician can 
check for the presence of parasites and other parameters through 
a PBS, low parasite burdens are difficult to observe on a PBS 
[14]. In particular, P. malariae malaria is usually chronic and as-
ymptomatic and exhibits a relatively low parasitic load, usually 
less than 5,000 parasites/μL of blood [15]. Furthermore, in P. 
ovale and P. malariae infections, if the infected red blood cells 
are damaged and their distinguishing morphologic features, 
such as fimbriated margins or contracted cells, are distorted, 
the diagnosis is more difficult [16]. Moreover, P. knowlesi, a 
newly discovered human plasmodia species, is similar in mor-
phology to P. falciparum and P. malariae, according to its blood 
stage [17]. Therefore, in the diagnosis of P. malariae infections, 
which are rare in Korea, a molecular test would be helpful for 
detecting and identifying the specific species involved. In this 
case, the patient had a low parasite burden, and parasites were 
not observed in her blood films, although she was symptomatic 
and had not undergone prophylactic therapy with antimalarial 
drugs. At the time of emergence of parasites in the peripheral 
blood, from the low parasite burden, travel history, and incuba-
tion time, we could expect the presence of a species uncom-
mon to our domestic area. However, the precise diagnosis at the 
species level was made with the aid of molecular tests.
  Relatively few studies have investigated the treatment of P. ma-
lariae malaria compared with the treatment of P. falciparum ma-
laria. Chloroquine is the first-line drug for P. malariae infections 
as well as for P. vivax and P. ovale. In general, P. malariae is 
known to be susceptible to chloroquine and to other treatments, 
including amodiaquine, mefloquine, and artemisinin [14]. It is 
very unusual for P. malariae to be resistant to chloroquine; how-
ever, a study has reported cases of persistent parasitemia 28 
days after the initial disease management, suggesting either 
new infection or late recrudescence of a chloroquine-resistant 
strain [18]. The parasites in this case, although showing nega-
tive conversion in PBS immediately after the initiation of therapy, 
did not respond to chloroquine. Instead, they responded to me-
floquine after a positive PCR result at the 1-month follow-up. 
Considering that P. malariae malaria is very rare in Korea, we 
could exclude the possibility of a new infection occurring in our 
patient, and late recrudescence of a chloroquine-resistant P. 
malariae strain was strongly suggested.
  In summary, an imported P. malariae infection showing late 
recrudescence of a chloroquine-resistant strain was confirmed 
by species-specific conventional and real-time PCR assays for 
18S rRNA. Due to difficulties in the diagnosis of the rare Plas-
modium species in Korea, molecular tests combined with mor-
phologic examination of the PBS would help to correctly diag-
nose and identify the parasites and would result in better clinical 
management of P. malariae infections. Hong YJ, et al.
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